Biapenem

Biapenem (CLI 86815; L 627; LJC 10627) a parenteral carbapenem antibacterial agent with a broad spectrum.

Product Specifications

CAS Number

[120410-24-4]

Product Name Alternative

CLI 86815; L 627; LJC 10627

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Antibiotic; Bacterial; Beta-lactamase

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/biapenem.html

Purity

98.31

Solubility

H2O : 10 mg/mL (ultrasonic)

Smiles

O=C1N2C(C([O-])=O)=C(SC(C3)CN4[N+]3=CN=C4)[C@H](C)[C@]2([H])[C@@]1([H])[C@H](O)C

Molecular Formula

C15H18N4O4S

Molecular Weight

350.39

Precautions

H302, H315, H319, H335

References & Citations

[1]Perry, C.M. and T. Ibbotson, Biapenem. Drugs, 2002. 62 (15) : p. 2221-34; discussion 2235.|[2]Kasahara, S., et al., [Clinical effects of biapenem on febrile neutropenia in patients with hematological malignancy]. Jpn J Antibiot, 2008. 61 (3) : p. 115-21.